Can We Appropriately Measure Appropriateness?⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.  by Vaitkus, Paul T.
Journal of the American College of Cardiology Vol. 57, No. 14, 2011
© 2011 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00
Published by Elsevier Inc. doi:10.1016/j.jacc.2010.11.034EDITORIAL COMMENT
Can We Appropriately
Measure Appropriateness?*
Paul T. Vaitkus, MD
Rockford, Illinois
“Competence, like truth, beauty, and contact lenses,
is in the eye of the beholder.”
—Laurence J. Peter (1)
(And one might add “appropriateness” to the list as well).
A few years ago, at a national interventional cardiology
meeting, the speaker regaled the audience with an anecdote
that may have been apocryphal but was entirely believable.
At some earlier meeting, this speaker had challenged his
audience with 3 sequential questions to which he invited a
show of hands. The first was, “Have any of you witnessed an
inappropriate coronary intervention?” in response to which
virtually all of the hands in the room were raised. The
second was, “Have any of you witnessed someone else in this
room conduct an inappropriate intervention?” The vast
majority of hands shot up. And finally, “Which of you
yourselves has performed an inappropriate intervention?”
See page 1546
None of the hands was raised. For the record, I will publicly
confess to having performed clinically inappropriate inter-
ventions but for a justifiable reason. As is true of most
interventionalists, I have partnered with noninterventional-
ists for all of my career, spanning both academia and private
practice. Confronted with a request by a nonintervention-
alist that I perform an intervention in a situation that of my
own accord I would not have elected to undertake, usually
because I did not think that the clinical circumstances
justified it, I viewed that my responsibility to my partners
was to provide a service that they could not provide for
themselves. If a properly trained, thoughtful cardiologist felt
that the intervention was clinically important, I acceded to
their judgment. Reasonable individuals confronted with the
same data set could reasonably reach very different conclu-
sions. Therein lies the principal conundrum of all measure-
ment of appropriateness.
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of Daiichi-Sankyo Inc.The study by Chan et al. (2) in this issue of the Journal
presented the data of an unusual “natural experiment” that
will not likely be readily replicated. The authors, aware in
advance of the development of the American College of
Cardiology’s (ACC’s) appropriate use criteria (AUC) for
coronary revascularization (3), provided the same clinical
scenarios and questions being used by the committee devel-
oping the AUC to a broader group of practicing cardiolo-
gists and queried them for their assessments of appropriate-
ness. The participating cardiologists were drawn from a
wide range of institutions and clinical backgrounds and were
entirely unaware of the impending public release of the
AUC. The findings of the study by Chan et al. (2) were that
although overall there was a moderately strong correlation
of overall appropriateness scoring by practicing cardiologists
and the AUC expert panel, individual scores frequently
varied widely.
These findings would make for merely interesting aca-
demic reading were it not for the potential administrative
applications of the AUC, particularly in the current envi-
ronment of universal health care reform. Of the many
undercurrents of health care reform that have generated
anxiety for physicians, the one that potentially most directly
relates to the AUC is that of seeking health care savings by
elimination of reimbursement for “unproven therapies” or
“inappropriate procedures.” It is also not a very large leap of
faith to suggest that physician-profiling efforts by govern-
ment and other payers might also seek to incorporate the
AUC. It is in this context that a critical review of appro-
priateness measurement is essential and wherein the current
study, and other lines of evidence, cast serious doubt that
the AUC is ready for “prime time.”
First, we must examine how “appropriateness” criteria
have been developed in the AUC and previous such at-
tempts. All such efforts have been variations on a committee
examining published clinical data. The approach was most
vigorously first used more than a decade ago by the RAND
Corporation (4). The assembled experts provide a numerical
assessment and then seek to reach group consensus. The
intrinsic methodologic limitations must be acknowledged.
The committee’s decisions—like any assemblage of humans
(including juries and the Supreme Court)—will reflect the
biases of the participants. Furthermore, consideration of any
consensus-seeking committee should raise the specter of
“groupthink,” which can lead to flawed conclusions in the
name of group cohesiveness. Although other dimensions on
which physicians are or will soon be profiled have, at least
nominally, a measurable outcome, “appropriateness” lacks a
quantifiable gold standard. When the appropriateness cri-
teria derived by different committees has been put to
empiric examination, the degree of agreement has been
decidedly poor (5). As conscientious, earnest, intelligent,
and well informed as the members of any of the disparate
committees might be, the fact that they publish contradic-
tory guidelines is not particularly surprising given the high
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efforts, the extreme cases and scenarios are not usually in
doubt. There are clear-cut situations in which interventions
may be either life saving or undeniably dangerous. It is the
vast, gray middle in which there is little agreement. This is
the very realm in which a “gold standard” of appropriate-
ness, if such a thing could possibly exist, would have the
greatest utility.
It is important to note that although published practice
guidelines and efforts such as the AUC are not intended
to be static, and certainly undergo revision and updating
as new data emerge, the process of revision is necessarily
slow and AUC-based physician profiling and reimburse-
ment strategies could potentially penalize physicians
who either generate pioneering data or are early adapters.
Two examples from the current version of the AUC—
percutaneous left-main coronary intervention and the open-
artery–hypothesis-driven late post–myocardial infarction
intervention—illustrate the issues. The current AUC places
both in the “inappropriate” category.
In the case of left-main intervention, large amounts of
data have been and continue to be published that this is a
viable clinical alternative (6). Had AUC-based profiling and
reimbursement already been in place, would the clinical
investigators who generated the new data, facing lack of
payment for their clinical efforts and adverse consequences
of negative personal “appropriateness” ratings, have been
inhibited in their clinical research efforts? Do we Americans
thus cede all future efforts at “pushing the envelope” to our
international colleagues?
Just proximate to the publication of the AUC, a well-
performed meta-analysis of the open-artery clinical trials
suggested that late intervention may confer a survival
advantage that was not identified in any of the individual
trials, each of which had less power than pooling of all
available data (7). Would the “appropriateness profile” of
the physician who now accepted the results of this newer
publication suffer adverse effects until the AUC are revised
several years hence?
If we examine the limitations of physician profiling on
other dimensions such as clinical outcomes or economics,
any such efforts based on “appropriateness” criteria become
all the more suspect.
Profiling physician performance on “hard” clinical end
points, such as revascularization procedure–related myo-
cardial infarction or mortality, has required decades of
rigorous empiric development and continuous ongoing
revision and recalibration of models (8). These efforts
underscore just how difficult it is to get it right, a rigor
that is simply not present in the “appropriateness” arena.
As was recently highlighted, other “clinical performance”
measures that lack a long history of comprehensive
case-mix adjustment serve to emphasize that they risk
misleading more than informing (9).
But even with perfect case-mix adjustments, public pro-
filing on clinical outcomes such as the ongoing publicdissemination of revascularization outcomes data in New
York state, the likelihood of unintended consequences is
often ignored in the zealous 1-dimensional efforts of bu-
reaucrats. One can reasonably argue that such initiatives
serve to undermine appropriate patient care as the score-
carded physicians become risk averse (10).
Profiling on economic outcomes has thus far proven to be
a morass. Substantial errors in the classification of physi-
cians have been identified (11). Some of the sources of the
erroneous profiles may not be easily amenable to improve-
ment. For example, although insufficient case-sample size is
one source of unreliability, adjustment of sample size by a
substantial amount reduces the probability of misclassifica-
tion only to a small degree (11). How to increase sample size
could be an issue without a solution. Although each payer
may initially be hampered by having data only on cases for
which they pay, even if all payers pooled their data into one
master database, a particular physician’s data are limited by
the number of cases he performed in a given span of time.
Increasing the span of time to cover several years then may
defeat one of the goals of such a profiling effort, that is,
encouraging improvement over time. What is to be gained
by scoring a physician on cases performed several years in
the past? Cost attribution is another nettlesome issue. A
cardiologist is profiled on the costs of caring for an inpatient
with a cardiac diagnosis, but another physician involved in
the case may order cardiac tests that I would have deemed
superfluous. How is this captured? To whom are the added
costs attributed? These issues have led RAND investigators
to conclude that “current methods of physician cost profil-
ing are not ready for prime time” (12).
Finally, there has been a modest quantity of data on the
application of previous “appropriateness” criteria as a
management tool. But first, we must expose an unsub-
stantiated bias of the regulators, financiers, and politi-
cians. Undeniably, geographic variations in usage of
procedures exist (13). These differences are all too fre-
quently and without qualification interpreted as evidence
of inappropriate “overutilization,” and the possibility of
substantial underutilization in areas of undersupply of
physicians and other health care resources is simply
ignored (14). Thus, while inside the Beltway, the discussion
will focus on how to use “appropriateness” criteria to quash
overutilization, the available empiric data suggest that “ap-
propriateness” criteria may very well be more sensitive to
exposing underutilization, not overutilization (15–17). But
the bias on the part of payers will be distinctly one-
directional. The Centers for Medicare & Medicaid Services
auditor, charged with containing costs, is not likely to
investigate cases of medically managed coronary artery
disease and question whether the patient should more
appropriately have been transported to the catheterization
laboratory.
So where does this leave us? The ACC expended re-
sources on developing the AUC and should be commended
for taking the lead before a federal agency decided it was
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sanctioned tool that the membership may not endorse, as
the current research suggests, perhaps the initiative needs to
be revisited and refined. Additional research may focus on to
what degree ACC members agree with the criteria or
whether a broader consensus may lead us to more convinc-
ing measures of appropriateness. In this era of electronic
data gathering, it would not be such an onerous effort to
reach out to the entire membership to voice their agreement
or disagreement with each of the appropriateness criteria.
Set it up on the ACC Web site and let all of us vote on it.
If 5,000 ACC members say an indication for percutaneous
coronary intervention is appropriate, maybe it really is
appropriate. And if 5,000 potential expert witnesses agree
that in a particular clinical setting, I should not have
performed a percutaneous coronary intervention, perhaps I
will refrain from doing so. Replicate the AUC experiment.
Set up half a dozen more committees and see if they come
up with concordant or contradictory criteria. Survey the
prospective committee members for their attitudes and
biases before they enter the discussion phase. If we intend to
profile the practicing interventionalists, why not also profile
the criteria generators? Check any tendencies of the Centers
for Medicare & Medicaid Services or others to misapply the
AUC as a physician-profiling or reimbursement policy tool.
Run some physician-profiling experiments and determine
the variability of measurement of case appropriateness in the
hands of potential auditors. If the AUC cannot be opera-
tionalized, then it should not be allowed to be.
Whatever methods the ACC decides upon, it is imper-
ative to gather more data to assess the degree to which the
membership does or does not support the AUC, to dem-
onstrate the strengths and flaws of how the AUC might be
applied in practice, and to demonstrate whether similar
appropriateness scores would be developed by alternate
methodologic approaches. All of these questions need to be
addressed before payers begin to adapt this tool to their
ends.
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